Showing posts with label Medicine. Show all posts
Showing posts with label Medicine. Show all posts

Thursday, November 17, 2016

Living and Dying in the Arms of Mother Russia

by Nomad

Russia

Here's a peek into some of the reasons why Russians, men, in particular, have a hard time surviving until what we consider middle-age. Sadly for the Russian government, there's not a single reason but a multitude of them. 


Russia is no country for old men. And it's not all that great for old women either. That's not an opinion but a fact.
According to a recent report by the Organization for Economic Cooperation and Development (OECD), most Russian citizens will not see their 71st birthday. But how does that stack up against other countries, you ask?

The life expectancy in the former Communist country lags nearly ten years behind the average in developed countries. That's also lower than countries with similar income levels such as Turkey, Mexico or Chile.

Russia ranked 43rd out of the 45 countries surveyed. The average life expectancy in Russia in 2013 was 70.7 years. but the life expectancy for Russian men is just 64 years. (For U.S. men, the average life expectancy is 76.)
Experts have made some conjectures on why Russians have such a hard time staying alive past their seventh decade.

Up in Smoke

Lifestyle choices are blamed for the poor showing, namely high rates of alcohol abuse, and smoking.
Back in 2013, Putin signed legislation that placed an increased tax on cigarettes raising the price to approximately $1.50 a pack.
(A smoker's paradise compared to most Western countries.)

Thursday, November 5, 2015

Did Texas Gov. Rick Perry Help Scuttle in a Medical Licence Revocation Case in Oklahoma?

by Nomad

Another allegation of abuse of power against former Texas governor Rick Perry has emerged.


Get Rid of This
Medical authorities in Oklahoma spent more than 3 years and $600,000 in an attempt to revoke the license of a doctor accused of performing operations that left patients paralyzed, in perpetual pain – or dead. Many of the charges against the surgeon were serious and deserved careful consideration. 

Yet all these efforts abruptly came to nothing after a call from Texas Governor Rick Perry to Oklahoma Governor Mary Fallin. if one report is correct,. 
According to one investigative organization, a memo recently found suggests that Perry called Fallin, a fellow Republican, on Dr. Steven Anagnost’s behalf as a favor to a generous campaign donor.
When Fallin’s general counsel, Steve Mullins, met with key staff members at the Oklahoma Board of Medical Licensure and Supervision in March 2013, Perry’s intervention was part of the discussion.
“He (Mullins) told us that he wasn’t here to interfere with the work of the board but Gov. Fallin didn’t want any more calls from Rick Perry about this, that Gov. Perry said it was a travesty and what would it take to make it go away,” Dr. Eric Frische, the medical board’s medical advisor, later wrote in a memo.

Saturday, October 17, 2015

How Three Asian Nations are Beating Outrageous Price-Gouging by American Pharmas

by Nomad

Some have started to question the exorbitant prices pharmaceutical companies charge the public. In Asia, we may be seeing a push back against what some see as price-gouging of the most desperate and vulnerable segment of the world's population: The sick and the poor.


In the recent past, Nomadic Politics examined, in two posts, alleged price-gouging for one company's drug for Hepatitis C. There are further developments to that story. First, let's re-cap.

The Breakthrough

The story begins with some very good news. It was reported last year that one orally-administered drug,  Sovaldi (sofosbuvir), has proved to be a breakthrough for the treatment of a silent killer virus, hepatitis C.  
From the clinical trial reports, researchers claimed that Sovaldi was not a life-long treatment but a genuine cure for the deadly disease itself. The therapy required a 12-week therapy but at the end, most of the patients would be free of the disease.  

Then came the bad news: Gilead Sciences, the patent-owner and developer of the drug, was definitely not a charity organization. It was a profit-making company which, according to Wikipedia, earned US $12.059 billion in 2014. 
It was immediately clear to everybody that the Hep C cure was not going to be given away free. Few, however, were expecting the price the company settled on. Sovaldi costs $1,000 a day, adding up to staggering $84,000 for a 12-week supply. 
The problem is obvious: at that price, a cure is out of reach of most patients in the world and even in rich countries.

Monday, February 23, 2015

The Anti-Vaccination Controversy: What the Amish and the Romans Have to Teach Us

 by Nomad

The question is pretty basic when it comes to the controversy about vaccinations. Are we really committed to progress or will be surrender to an illusion of past stability and simplicity?


The anti-vaccination movement is a good reminder that progress is not a steadily upward climb. It's something we tend to forget sometimes. This safe and convenient means of prevention to a disease that has ravaged civilization should, according to common sense, be hailed as a victory of humanity.
Instead it is viewed with superstitious suspicious and ignorance. 
In fact, the whole idea of progress is actually a quite recent phenomena and shouldn't be taken for granted.

Friday, July 4, 2014

The Mysterious 1942 Death of Dr. Foster and Tesla's Healing Rays

by Nomad

Unearthed from the archives here is the curious death of Dr. Foster, a young and promising Manhattan physician. Was his sudden breakdown and mysterious death in 1942 linked to the suppression of a revolutionary medical discovery by Nikola Tesla.


Some might consider one of my hobbies to be a little eccentric. I like to go through the old newspapers and find odd news or snapshots of long-forgotten drama. To me, it's fascinating how often you find little treasures or peculiar mysteries that have long been buried in the past.
While the following post is not technically a "political" issue, I thought it was interesting enough to pass along. I will admit that there is a great deal of speculation involved and possibly there are no connections to the events in the post.

The Foster Mystery

With that said, hop into my time machine and we will return to January 1942 to investigate the death of a young Manhattan doctor.

Dr. Allyn King Foster Death
Doctor's Mystery Death 
Opens 3 Investigations
Son of Late Boro Pastor Had Fractured Larynx, Autopsy at Bellevue Reveals

( January 19, 1942) 
A triple investigation was under way today into the death at Bellevue Hospital, Manhattan, of Dr. Allyn King Foster, Jr. 37 of E. 96th St. Manhattan, son of the late Rev. Dr. Allyn King Foster, pastor of the Washington Avenue and Marcy Avenue Baptist Churches.

The doctor was taken to Bellevue last Monday after a policeman had found him without hat or overcoat in a dazed condition at W. 56th St. and 6th Ave. Manhattan. His office was at 136 E. 57th St. Manhattan. He was placed in the psychiatric division. It was said that because he was uncooperative" forcible feeding had to be resorted to several times. He died Saturday evening while a friend of his family was arranging his transfer to another hospital.

Wife Asks Autopsy
Dr. Foster's wife, Elsa, requested an autopsy. As a result of the findings by Assistant Medical Examiner Philip Goldstein, Deputy Chief Medical Examiner ordered an examination. Assistant District Attorney Jacob Grumet of the Homicide Bureau of the New York County prosecutor's office, started an inquiry. 
A third was begun by police of W. 54th St. Station, the precinct in which he was found., and by the police of the E. 35th st. Station, the Bellevue precinct, because of the possibility of his having been injured in the hospital. 

Larynx Fractured
It was stated that Dr. Foster was found to have a fractured larynx, foreign matter in his bronchial tubes, and evidence of asphyxiation. Police said a fractured larynx was frequently an indication of a mugging- a holdup in which one bandit, standing behind the victim, throws an arm around his throat, choking him and forcing his head back while a second goes through his pockets.

Born in Cornwall, N.Y., Dr. Foster  was educated at Brooklyn Poly Prep. Colgate University, Rush Medical School of the University of Chicago and interned at St. Luke's Hospital. He was a junior assistant surgeon in his outpatient department, assistant surgeon at Broad Street Hospital and clinical assistant surgeon in the outpatient department of Laying -in- Hospital.

This tragic story echoes another unsolved mystery: the 2010 death of Jack Wheeler

So to sum up, a young Brooklyn doctor is found on the streets of Manhattan, wandering lost and incoherent. It's a little unusual that alcohol or drugs are not mentioned. At least it was not reported. Added to that, no injuries were reported at the time. Prior to that moment, there had been no sign of mental issues according to his widow. Police pick him up and he is placed under observation at a mental facility.
There, five days later, he is found dead. 

While the cause of his death suggests either hanging or strangulation of some sort, that possibility is never expressed in the newspaper item. Additionally, (and rather, surprisingly) the possibility of suicide is not mentioned, suggesting that it was obvious that he did not hang himself.

Thursday, March 6, 2014

Cure for Hepatitis C: The Politics and Profits behind a Breakthrough

by Nomad

A breakthrough in curing a silent killer, Hepatitis C, should mean that patients will have a new lease on life. But unless they are extraordinarily wealthy or they  live in a state that expanded Medicaid in the wake of the Affordable Care Act, these people will be at the mercy of the profit-driven free market. So for most of the uninsured or under-insured Americans, it will mean no cure at all.

Good News 
Even for researchers who are loathe to use the word "cure," there's no question that the news is very good,

The Denver Post is reporting of a breakthrough drug for hepatitis C in clinical trials at the University of Colorado Hospital. This new anti-viral is being called the blockbuster cure for patients who have long had to endure debilitating treatment for this liver-destroying disease.

Astoundingly, Sovaldi, a daily-dose pill manufactured by California-based Gilead Sciences Inc., has cured about 90 percent of patients in only 12 weeks when used with older drugs, studies nationwide have found.
In other words, it's a very nearly the cure for a killer. Not life-long treatment like the HIV drug therapy, but an actual eradication of the affliction. 
A big big deal.

Silent Killer of the Baby Boomers
This is a disease that infects an estimated 150–200 million people around the world. In the US the majority of the estimated 3.2 million people with chronic hepatitis C virus (HCV) are baby boomer adults. Seventy-three percent of hepatitis C deaths were reported among those 45 to 64 years old.
For every 100 people who contract the virus, 75 will develop chronic infection. About 5 to 20 will develop cirrhosis over the next 20 to 30 years. Between 1 and 5 will die of cirrhosis and liver cancer. Meaning, more than 350 000 people die every year from hepatitis C-related liver diseases. The disease is found worldwide with some countries having chronic infection rates as high as 5% and above.

One of the particularly dangerous aspects of the disease is its insidious nature. Most of those infected with the virus do not know that they have it, which means they could easily be spreading it to others via exposure to blood—or, occasionally, sexual contact. The main mode of transmission in countries with infection rates above 5% is attributed to unsafe injections using contaminated equipment.

"In almost every country it is a significant public health problem, points out Charles Gore, president of the World Hepatitis Alliance, "and, in some, such as Egypt, which has 10% to 15% of its population living with hepatitis C, and Vietnam, where the prevalence of hepatitis B is 15% to 20%, it is simply overwhelming."
So curing this disease is unquestionably a great triumph for science. It's something that the researchers should be proud of. 
There is however one problem.

Now...The Bad News
Sovaldi was approved by the Food and Drug Administration (FDA) last December, but it won't be cheap. Sovaldi costs $1,000 a day and that adds up to staggering $84,000 for a 12-week supply.